Digital olfaction mimics the human sense of smell by capturing odor signatures for display and analysis. A silicon photonic solution functionalized with biosensors is sensitive enough to distinguish hundreds of odors while reducing sensor size and costs. This low cost, high volume solution is enabling innovation in automotive, consumer appliance and digital health applications.
Tristan ensures the development of global strategic partnerships and customer relationships to meet Aryballe's long term vision for the potential of digital olfaction. Prior to founding Aryballe Technologies in 2014, Tristan was the founder and CEO of PX'Therapeutics which specialized in the development of therapeutic proteins. PX'Therapeutics was sold to Aguettan Biotech in 2012. Tristan holds a PhD in Cell Biology from Grenoble University (France).
Based in Grenoble, France, Aryballe combines biochemistry, advanced optics and machine learning to mimic the human sense of smell. Founded in 2014, Aryballe released its first product, the digital nose NeOse Pro, in early 2018. Fast, portable and sensitive to hundreds of odors, NeOse Pro captures odor signatures for display and analysis via software solutions that enable better decision making for R&D, quality control, manufacturing and end user experiences. With operations in France and the USA, Aryballe works with global leaders in automotive, consumer appliances and flavor & fragrance industries.
